These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 21596100)

  • 1. Isoprostanes and asthma.
    Voynow JA; Kummarapurugu A
    Biochim Biophys Acta; 2011 Nov; 1810(11):1091-5. PubMed ID: 21596100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insights into oxidative stress: the isoprostanes.
    Montuschi P; Barnes P; Roberts LJ
    Curr Med Chem; 2007; 14(6):703-17. PubMed ID: 17346157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of prostaglandins E2 and D2 via the isoprostane pathway: a mechanism for the generation of bioactive prostaglandins independent of cyclooxygenase.
    Gao L; Zackert WE; Hasford JJ; Danekis ME; Milne GL; Remmert C; Reese J; Yin H; Tai HH; Dey SK; Porter NA; Morrow JD
    J Biol Chem; 2003 Aug; 278(31):28479-89. PubMed ID: 12746435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E-Ring Isoprostanes Stimulate a Cl Conductance in Airway Epithelium via Prostaglandin E2-Selective Prostanoid Receptors.
    Seto V; Hirota C; Hirota S; Janssen LJ
    Am J Respir Cell Mol Biol; 2008 Jan; 38(1):88-94. PubMed ID: 17673688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contractile effects of 15-E2t-isoprostane and 15-F2t-isoprostane on chicken embryo ductus arteriosus.
    van der Sterren S; Villamor E
    Comp Biochem Physiol A Mol Integr Physiol; 2011 Aug; 159(4):436-44. PubMed ID: 21565280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isoprostanes, biomarkers of lipid peroxidation in humans. Part 3: Biomarkers and mediators in vascular physiology and disease].
    Cracowski JL; Berdeaux O; Durand T
    Pathol Biol (Paris); 2005 Jul; 53(6):364-8. PubMed ID: 16004949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The isoprostanes - unique products of arachidonate peroxidation: their role as mediators of oxidant stress.
    Morrow JD
    Curr Pharm Des; 2006; 12(8):895-902. PubMed ID: 16533158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The isoprostanes: unique products of arachidonic acid oxidation-a review.
    Fam SS; Morrow JD
    Curr Med Chem; 2003 Sep; 10(17):1723-40. PubMed ID: 12871112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fatty acid oxidation product 15-A3t-isoprostane is a potent inhibitor of NFκB transcription and macrophage transformation.
    Brooks JD; Musiek ES; Koestner TR; Stankowski JN; Howard JR; Brunoldi EM; Porta A; Zanoni G; Vidari G; Morrow JD; Milne GL; McLaughlin B
    J Neurochem; 2011 Nov; 119(3):604-16. PubMed ID: 21838782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isoprostanes in fetal and neonatal health and disease.
    Belik J; González-Luis GE; Perez-Vizcaino F; Villamor E
    Free Radic Biol Med; 2010 Jan; 48(2):177-88. PubMed ID: 19854268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of the major urinary metabolite of 15-F2t-isoprostane (8-iso-PGF2alpha) by a stable isotope dilution mass spectrometric assay.
    Morrow JD; Zackert WE; Yang JP; Kurhts EH; Callewaert D; Dworski R; Kanai K; Taber D; Moore K; Oates JA; Roberts LJ
    Anal Biochem; 1999 May; 269(2):326-31. PubMed ID: 10222005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoprostanes: markers and mediators of oxidative stress.
    Montuschi P; Barnes PJ; Roberts LJ
    FASEB J; 2004 Dec; 18(15):1791-800. PubMed ID: 15576482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of isoprostanes in the cardiovascular system: implications of isoprostane-mediated thromboxane A2 receptor activation.
    Bauer J; Ripperger A; Frantz S; Ergün S; Schwedhelm E; Benndorf RA
    Br J Pharmacol; 2014 Jul; 171(13):3115-31. PubMed ID: 24646155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoprostanes.
    Roberts LJ; Milne GL
    J Lipid Res; 2009 Apr; 50 Suppl(Suppl):S219-23. PubMed ID: 18957694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pulmonary biology of isoprostanes.
    Janssen LJ; Catalli A; Helli P
    Antioxid Redox Signal; 2005; 7(1-2):244-55. PubMed ID: 15650412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The isoprostanes: their role as an index of oxidant stress status in human pulmonary disease.
    Morrow JD; Roberts LJ
    Am J Respir Crit Care Med; 2002 Dec; 166(12 Pt 2):S25-30. PubMed ID: 12471085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological actions of isoprostane metabolites and phytoprostanes in human and bovine pulmonary smooth muscles.
    Liu C; Tazzeo T; Guy A; Durand T; Janssen LJ
    Prostaglandins Leukot Essent Fatty Acids; 2007 Jan; 76(1):57-64. PubMed ID: 17049219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2alpha).
    Dworski R; Roberts LJ; Murray JJ; Morrow JD; Hartert TV; Sheller JR
    Clin Exp Allergy; 2001 Mar; 31(3):387-90. PubMed ID: 11260149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the biochemistry and clinical relevance of the isoprostane pathway.
    Musiek ES; Yin H; Milne GL; Morrow JD
    Lipids; 2005 Oct; 40(10):987-94. PubMed ID: 16382569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoprostanes and phytoprostanes: Bioactive lipids.
    Durand T; Bultel-Poncé V; Guy A; El Fangour S; Rossi JC; Galano JM
    Biochimie; 2011 Jan; 93(1):52-60. PubMed ID: 20594988
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.